Lorenzo Ph.D.'s Colleagues at Palladio Biosciences
Lorenzo Ph.D.'s Contact Details
HQ
N/A
N/A
Location
Company
Palladio Biosciences
Palladio Biosciences
Lorenzo Ph.D.'s Company Details
Palladio Biosciences, Inc., is a Centessa company. Our first product, lixivaptan, is in Phase 3 clinical development for the treatment of autosomal polycystic kidney disease (ADPKD). ADPKD causes numerous fluid-filled cysts to grow in both kidneys. It is a life-limiting, chronic and progressive disease. It is the 4th leading cause of kidney failure and carries significant financial and emotional burden, affecting entire families. There is no cure for PKD. We are developing lixivaptan as a safe and effective agent to be used chronically to prevent the progression of PKD.
Frequently Asked Questions about Lorenzo Ph.D.
Lorenzo Ph.D. currently works for Palladio Biosciences; Inc..
Lorenzo Ph.D.'s role at Palladio Biosciences; Inc. is Founder and COO.
Lorenzo Ph.D.'s email address is ***@palladiobio.com. To view Lorenzo Ph.D.'s full email address, please signup to ConnectPlex.
Lorenzo Ph.D. works in the Biotechnology industry.
Lorenzo Ph.D.'s colleagues at Palladio Biosciences are Neil MD, Ron Dadino, Shana Abbott, Lorenzo Pellegrini, Harold Lee, Neil Shusterman, Anita Fauchier and others.
Lorenzo Ph.D.'s phone number is N/A